$OPGN; OpGen, Inc., a precision medicine company, develops and sells molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases.
It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MRDOs).
The company's products include Acuitas AMR Gene Panel, an in vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance in urine specimens or bacterial colonies isolated from urine and other body sites;
and QuickFISH and PNA FISH products, which are diagnostic tests for the identification of various infectious pathogens.
In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics offerings, which combine clinical lab test results with patient and hospital information, and provide analytics and insights to enable manage MDROs in the hospital and patient care environment.
The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Curetis N.V. in Liquidation 10% Owner Apr 23 Sale 2.17 46,612 101,148 1,622,568 Apr 24 09:31 AM
Curetis N.V. in Liquidation 10% Owner Apr 22 Sale 2.24 42,375 94,920 1,669,180 Apr 24 09:31 AM
Curetis N.V. in Liquidation 10% Owner Apr 21 Sale 2.30 95,609 219,901 1,711,555 Apr 21 08:09 PM
Curetis N.V. in Liquidation 10% Owner Apr 20 Sale 2.35 55,142 129,584 1,807,164 Apr 21 08:09 PM
Curetis N.V. in Liquidation 10% Owner Apr 17 Sale 2.46 165,902 408,119 1,862,306 Apr 21 08:09 PM
DEC TIMOTHY C Cheif Financial Officer Nov 10 Option Exercise 0.00 12 0 345 Nov 12 06:33 PM
Market Data 
Markets 
AI
